Literature DB >> 13047352

Resistance of bacteria to erythromycin.

T H HAIGHT, M FINLAND.   

Abstract

Entities:  

Keywords:  DIPLOCOCCUS PNEUMONIAE/resistance and sensitivity; ERYTHROMYCIN/effects; MICROCOCCUS/resistance and sensitivity; STREPTOCOCCUS/resistance and sensitivity

Mesh：

Substances：

Year:  1952        PMID： 13047352     DOI： 10.3181/00379727-81-19816

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  5 in total

1.  Ocular penetration of erythromycin.

Authors:  E I QUERENGESSER; H L ORMSBY
Journal:  Can Med Assoc J       Date:  1955-02-01       Impact factor: 8.262

2.  Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporin.

Authors:  Klaudia Kosowska; Dianne B Hoellman; Gengrong Lin; Catherine Clark; Kim Credito; Pamela McGhee; Bonifacio Dewasse; Bülent Bozdogan; Stuart Shapiro; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

Review 3.  Antibiotic resistance: bioinformatics-based understanding as a functional strategy for drug design.

Authors:  Umar Ndagi; Abubakar A Falaki; Maryam Abdullahi; Monsurat M Lawal; Mahmoud E Soliman
Journal:  RSC Adv       Date:  2020-05-14       Impact factor: 4.036

4.  In vitro induction of resistance to erythromycin by its metabolite.

Authors:  J Majer
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

5.  Evolution of antibiotic cross-resistance and collateral sensitivity in Staphylococcus epidermidis using the mutant prevention concentration and the mutant selection window.

Authors:  Natalie Ann Lozano-Huntelman; Nina Singh; Alondra Valencia; Portia Mira; Maral Sakayan; Ian Boucher; Sharon Tang; Kelley Brennan; Crystal Gianvecchio; Sorel Fitz-Gibbon; Pamela Yeh
Journal:  Evol Appl       Date:  2020-02-25       Impact factor: 5.183
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.